Comments

AbbVie

ABBVNYSE
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$172.32
00.00%
Pre-Market: Jul 19, 5:26 PM EDT
15 minutes delayed
The dividend Ex-Date was 7 days ago
Q2 2024 Earnings in 3 days from now on Thu Jul 25th, before the market open
Conference call scheduled in 3 days at 9:00 AM Click to view the webcast
AbbVie (ABBV) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesGovernment TradesShort Interest
Consensus Rating1
Overweight
Highest Price Target1
$214.00
Lowest Price Target1
$133.00
Consensus Price Target1
$173.00

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

AbbVie (NYSE:ABBV) Stock, Analyst Ratings, Price Targets, Forecasts

AbbVie Inc has a consensus price target of $173 based on the ratings of 31 analysts. The high is $214 issued by BMO Capital on July 19, 2024. The low is $133 issued by CFRA on February 9, 2023. The 3 most-recent analyst ratings were released by BMO Capital, Morgan Stanley, and Cantor Fitzgerald on July 19, 2024, July 11, 2024, and July 9, 2024, respectively. With an average price target of $203.33 between BMO Capital, Morgan Stanley, and Cantor Fitzgerald, there's an implied 18.00% upside for AbbVie Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Mar
2
Apr
1
May
2
Jun
4
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

BMO Capital
Morgan Stanley
Cantor Fitzgerald
Piper Sandler
HSBC

1calculated from analyst ratings

Analyst Ratings for AbbVie

Buy NowGet Alert
07/19/2024Buy Now24.19%BMO Capital
Evan David Seigerman
$180 → $214MaintainsOutperformGet Alert
07/11/2024Buy Now13.74%Morgan Stanley
Terence Flynn
$191 → $196MaintainsOverweightGet Alert
07/09/2024Buy Now16.06%Cantor Fitzgerald
Louise Chen
$200 → $200ReiteratesOverweight → OverweightGet Alert
07/02/2024Buy Now10.26%Piper Sandler
Christopher Raymond
$190 → $190MaintainsOverweightGet Alert
06/20/2024Buy Now16.06%Cantor Fitzgerald
Louise Chen
$200 → $200ReiteratesOverweight → OverweightGet Alert
06/18/2024Buy Now10.26%Piper Sandler
Christopher Raymond
$185 → $190MaintainsOverweightGet Alert
06/05/2024Buy Now7.36%HSBC
Rajesh Kumar
 → $185UpgradeHold → BuyGet Alert
05/17/2024Buy Now16.06%Cantor Fitzgerald
Louise Chen
 → $200Initiates → OverweightGet Alert
04/29/2024Buy Now8.52%Barclays
Carter Gould
$195 → $187MaintainsOverweightGet Alert
04/29/2024Buy Now4.46%BMO Capital
Evan David Seigerman
$195 → $180MaintainsOutperformGet Alert
03/27/2024Buy Now13.16%Barclays
Carter Gould
$185 → $195MaintainsOverweightGet Alert
03/22/2024Buy Now10.26%Guggenheim
Vamil Divan
$188 → $190MaintainsBuyGet Alert
02/06/2024Buy Now9.68%Raymond James
Gary Nachman
$181 → $189MaintainsOutperformGet Alert
02/06/2024Buy Now13.16%Truist Securities
Robyn Karnauskas
$180 → $195MaintainsBuyGet Alert
02/05/2024Buy Now9.68%Raymond James
Gary Nachman
$181 → $189MaintainsOutperformGet Alert
02/05/2024Buy Now13.16%BMO Capital
Evan David Seigerman
$187 → $195MaintainsOutperformGet Alert
02/05/2024Buy Now7.36%Barclays
Carter Gould
$175 → $185MaintainsOverweightGet Alert
01/29/2024Buy Now—William Blair
Tim Lugo
—UpgradeMarket Perform → OutperformGet Alert
01/23/2024Buy Now1.56%Barclays
Carter Gould
$170 → $175MaintainsOverweightGet Alert
12/18/2023Buy Now-9.47%HSBC
Rajesh Kumar
$167 → $156DowngradeBuy → HoldGet Alert
12/11/2023Buy Now0.39%Goldman Sachs
Chris Shibutani
 → $173UpgradeNeutral → BuyGet Alert
12/01/2023Buy Now5.04%Raymond James
Gary Nachman
$177 → $181MaintainsOutperformGet Alert
11/09/2023Buy Now-12.95%Deutsche Bank
James Shin
 → $150Initiates → HoldGet Alert
10/30/2023Buy Now13.74%Morgan Stanley
Terence Flynn
$193 → $196MaintainsOverweightGet Alert
10/30/2023Buy Now-1.35%Barclays
Carter Gould
$160 → $170UpgradeEqual-Weight → OverweightGet Alert
10/11/2023Buy Now12%Morgan Stanley
Terence Flynn
$189 → $193MaintainsOverweightGet Alert
09/29/2023Buy Now2.72%Raymond James
Gary Nachman
 → $177Initiates → OutperformGet Alert
07/28/2023Buy Now-1.35%Piper Sandler
Christopher Raymond
$163 → $170MaintainsOverweightGet Alert
07/25/2023Buy Now—William Blair
Tim Lugo
—Initiates → Market PerformGet Alert
07/14/2023Buy Now-3.09%HSBC
Rajesh Kumar
 → $167Initiates → BuyGet Alert
07/11/2023Buy Now5.62%Morgan Stanley
Terence Flynn
$182 → $182ReiteratesOverweight → OverweightGet Alert
04/28/2023Buy Now-0.77%Guggenheim
Vamil Divan
$172 → $171MaintainsBuyGet Alert
04/28/2023Buy Now5.62%Morgan Stanley
Terence Flynn
$181 → $182MaintainsOverweightGet Alert
04/28/2023Buy Now13.16%Wells Fargo
Mohit Bansal
$200 → $195MaintainsOverweightGet Alert
04/13/2023Buy Now-7.15%Barclays
Carter Gould
$155 → $160MaintainsEqual-WeightGet Alert
04/10/2023Buy Now5.04%Morgan Stanley
Terence Flynn
$178 → $181MaintainsOverweightGet Alert
04/05/2023Buy Now—Argus Research
Jasper Hellweg
—DowngradeBuy → HoldGet Alert
03/01/2023Buy Now-0.19%Guggenheim
Vamil Divan
 → $172Initiates → BuyGet Alert
02/22/2023Buy Now—Wolfe Research
Tim Anderson
—DowngradeOutperform → Peer PerformGet Alert
02/10/2023Buy Now-11.79%UBS
Navin Jacob
$150 → $152MaintainsNeutralGet Alert
02/10/2023Buy Now-11.21%SVB Leerink
David Risinger
$135 → $153UpgradeUnderperform → Market PerformGet Alert
02/10/2023Buy Now-10.63%Atlantic Equities
Steve Chesney
$157 → $154MaintainsNeutralGet Alert
02/10/2023Buy Now3.3%Morgan Stanley
Terence Flynn
$182 → $178MaintainsOverweightGet Alert
02/10/2023Buy Now-5.41%Piper Sandler
Christopher Raymond
$157 → $163MaintainsOverweightGet Alert
02/09/2023Buy Now4.46%Truist Securities
Robyn Karnauskas
 → $180Reiterates → BuyGet Alert
02/09/2023Buy Now-4.25%Evercore ISI Group
Gavin Clark-Gartner
$159 → $165MaintainsOutperformGet Alert
02/09/2023Buy Now-22.82%CFRA—$151 → $133DowngradeHold → SellGet Alert
02/06/2023Buy Now-3.09%BMO Capital
Gary Nachman
$169 → $167MaintainsOutperformGet Alert
01/31/2023Buy Now-12.95%UBS
Navin Jacob
$147 → $150MaintainsNeutralGet Alert
01/17/2023Buy Now-8.89%Piper Sandler
Christopher Raymond
$155 → $157MaintainsOverweightGet Alert
01/05/2023Buy Now4.46%Truist Securities
Robyn Karnauskas
$160 → $180MaintainsBuyGet Alert
12/20/2022Buy Now-10.63%Evercore ISI Group
Gavin Clark-Gartner
$156 → $154MaintainsOutperformGet Alert
12/14/2022Buy Now-4.25%B of A Securities
Geoff Meacham
$162 → $165MaintainsNeutralGet Alert
12/08/2022Buy Now-1.93%Exane BNP Paribas
Navaan Ty
 → $169Initiates → NeutralGet Alert
12/06/2022Buy Now5.62%Morgan Stanley
Matthew Harrison
$178 → $182MaintainsOverweightGet Alert
12/05/2022Buy Now-5.99%B of A Securities
Geoff Meacham
$160 → $162MaintainsNeutralGet Alert
11/18/2022Buy Now-1.35%Credit Suisse
Trung Huynh
 → $170Initiates → OutperformGet Alert
11/08/2022Buy Now—Societe Generale
Justin Smith
—DowngradeBuy → HoldGet Alert
10/31/2022Buy Now-14.69%UBS
Navin Jacob
$146 → $147MaintainsNeutralGet Alert
10/31/2022Buy Now-12.37%CFRA—$168 → $151DowngradeBuy → HoldGet Alert
10/31/2022Buy Now-8.89%Atlantic Equities
Steve Chesney
$162 → $157MaintainsNeutralGet Alert
10/31/2022Buy Now3.3%Morgan Stanley
Matthew Harrison
$185 → $178MaintainsOverweightGet Alert
10/31/2022Buy Now-1.93%BMO Capital
Gary Nachman
$170 → $169MaintainsOutperformGet Alert
10/31/2022Buy Now-10.05%Barclays
Carter Gould
$160 → $155MaintainsEqual-WeightGet Alert
10/11/2022Buy Now7.36%Morgan Stanley
Matthew Harrison
$188 → $185MaintainsOverweightGet Alert
09/30/2022Buy Now-21.66%SVB Leerink
David Risinger
$140 → $135MaintainsUnderperformGet Alert
09/14/2022Buy Now9.1%Morgan Stanley
Terence Flynn
 → $188Reiterates → OverweightGet Alert
08/24/2022Buy Now-10.05%Argus Research
Jasper Hellweg
$165 → $155MaintainsBuyGet Alert
08/01/2022Buy Now-10.05%Piper Sandler
Christopher Raymond
$160 → $155MaintainsOverweightGet Alert
08/01/2022Buy Now-1.35%BMO Capital
Gary Nachman
$172 → $170MaintainsOutperformGet Alert
08/01/2022Buy Now-15.27%UBS
Colin Bristow
$154 → $146MaintainsNeutralGet Alert
08/01/2022Buy Now9.1%Morgan Stanley
Matthew Harrison
$191 → $188MaintainsOverweightGet Alert
08/01/2022Buy Now-7.15%Barclays
Carter Gould
$174 → $160MaintainsEqual-WeightGet Alert
08/01/2022Buy Now-5.99%Atlantic Equities
Steve Chesney
$178 → $162MaintainsNeutralGet Alert
07/29/2022Buy Now-7.15%Truist Securities
Robyn Karnauskas
 → $160Reiterates → BuyGet Alert
07/15/2022Buy Now-21.66%Berenberg
Luisa Hector
 → $135ReiteratesHold → HoldGet Alert
07/08/2022Buy Now10.84%Morgan Stanley
Terence Flynn
$188 → $191MaintainsOverweightGet Alert
06/21/2022Buy Now-9.47%B of A Securities
Geoff Meacham
 → $156Reiterates → NeutralGet Alert
05/23/2022Buy Now-18.76%SVB Leerink
David Risinger
 → $140Initiates → UnderperformGet Alert
05/20/2022Buy Now-21.66%Berenberg
Luisa Hector
$115 → $135MaintainsHoldGet Alert
05/02/2022Buy Now-4.25%CFRA—$154 → $165MaintainsBuyGet Alert
05/02/2022Buy Now9.1%Morgan Stanley
Matthew Harrison
$192 → $188MaintainsOverweightGet Alert
05/02/2022Buy Now16.06%Wells Fargo
Mohit Bansal
$165 → $200MaintainsOverweightGet Alert
05/01/2022Buy Now-1.35%Wolfe Research
Tim Anderson
$172 → $170MaintainsOutperformGet Alert
04/29/2022Buy Now-7.15%Truist Securities
Robyn Karnauskas
 → $160Reiterates → BuyGet Alert
04/25/2022Buy Now0.97%BMO Capital
Gary Nachman
$161 → $174MaintainsOutperformGet Alert
04/22/2022Buy Now-9.47%B of A Securities
Geoff Meacham
$152 → $156MaintainsNeutralGet Alert
04/14/2022Buy Now4.46%TD Cowen
Steve Scala
$150 → $180MaintainsOutperformGet Alert
04/12/2022Buy Now-18.76%Goldman Sachs
Chris Shibutani
$122 → $140MaintainsNeutralGet Alert
04/12/2022Buy Now0.97%Barclays
Carter Gould
$150 → $174MaintainsEqual-WeightGet Alert
04/06/2022Buy Now11.42%Morgan Stanley
Terence Flynn
$142 → $192MaintainsOverweightGet Alert
04/01/2022Buy Now0.97%CFRA—$151 → $174MaintainsBuyGet Alert
03/17/2022Buy Now-11.79%B of A Securities
Geoff Meacham
$145 → $152MaintainsNeutralGet Alert
03/01/2022Buy Now-1.35%Citigroup
Andrew Baum
$155 → $170ReiteratesBuy → BuyGet Alert
02/28/2022Buy Now-33.26%Berenberg
Luisa Hector
 → $115ReiteratesHold → HoldGet Alert
02/28/2022Buy Now-14.69%UBS
Colin Bristow
$129 → $147DowngradeBuy → NeutralGet Alert
02/23/2022Buy Now-6.57%BMO Capital
Gary Nachman
$154 → $161MaintainsOutperformGet Alert
02/15/2022Buy Now-7.15%Truist Securities
Robyn Karnauskas
$135 → $160MaintainsBuyGet Alert
02/04/2022Buy Now-3.67%Mizuho
Vamil Divan
$154 → $166MaintainsBuyGet Alert
02/03/2022Buy Now-29.2%Goldman Sachs
Chris Shibutani
$117 → $122MaintainsNeutralGet Alert

FAQ

Q

What is the target price for AbbVie (ABBV) stock?

A

The latest price target for AbbVie (NYSE:ABBV) was reported by BMO Capital on July 19, 2024. The analyst firm set a price target for $214.00 expecting ABBV to rise to within 12 months (a possible 24.19% upside). 29 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for AbbVie (ABBV)?

A

The latest analyst rating for AbbVie (NYSE:ABBV) was provided by BMO Capital, and AbbVie maintained their outperform rating.

Q

When was the last upgrade for AbbVie (ABBV)?

A

The last upgrade for AbbVie Inc happened on June 5, 2024 when HSBC raised their price target to $185. HSBC previously had a hold for AbbVie Inc.

Q

When was the last downgrade for AbbVie (ABBV)?

A

The last downgrade for AbbVie Inc happened on December 18, 2023 when HSBC changed their price target from $167 to $156 for AbbVie Inc.

Q

When is the next analyst rating going to be posted or updated for AbbVie (ABBV)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AbbVie, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AbbVie was filed on July 19, 2024 so you should expect the next rating to be made available sometime around July 19, 2025.

Q

Is the Analyst Rating AbbVie (ABBV) correct?

A

While ratings are subjective and will change, the latest AbbVie (ABBV) rating was a maintained with a price target of $180.00 to $214.00. The current price AbbVie (ABBV) is trading at is $172.32, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch